Related Experiment Video
Updated: Aug 3, 2026
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Osteomyelitis in patients with systemic lupus erythematosus
Kun-Chan Wu1, Tsung-Chieh Yao, Kuo-Wei Yeh
1Division of Allergy, Asthma and Rheumatology, Department of Pediatrics, Chang Gung Children's Hospital, 5 Fu-Hsin Street, Kueishan, Taoyuan, Taiwan.
The Journal of Rheumatology
|July 2, 2004
Summary
Osteomyelitis is a serious risk for patients with systemic lupus erythematosus (SLE), especially those with active disease, kidney issues, and on immunosuppressants. Early diagnosis and treatment are crucial to prevent severe outcomes.
Area of Science:
- Rheumatology
- Infectious Diseases
- Clinical Medicine
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease that can increase susceptibility to infections.
- Osteomyelitis, a bone infection, can be a severe complication in immunocompromised individuals.
Purpose of the Study:
- To define the clinical characteristics and identify risk factors for osteomyelitis in patients diagnosed with SLE.
- To improve the understanding of this specific patient population to guide clinical management.
Main Methods:
- A retrospective review of 11 cases of patients with both SLE and osteomyelitis between 1981 and 2001.
- Analysis focused on predisposing factors, clinical presentation, laboratory findings, and patient outcomes.
Main Results:
- Osteomyelitis in SLE patients commonly presented with focal pain and fever, often affecting long bones (Salmonella) or vertebrae (Staphylococcus aureus).
- Key risk factors included active SLE, chronic renal disease, and intensive immunosuppressive therapy. Laboratory results indicated active inflammation and infection.
- Outcomes varied, with some patients experiencing long-term deficits or mortality, highlighting poor prognostic indicators like delayed diagnosis and vertebral involvement.
Conclusions:
- Osteomyelitis should be strongly considered in SLE patients with osteoarticular pain, particularly those with active disease, renal compromise, and on potent immunosuppressants.
- Empirical antimicrobial therapy should target Salmonella for long bone infections and S. aureus for vertebral infections.
- Prompt recognition and treatment are vital to mitigate long-term complications and mortality in this vulnerable patient group.
